Usefulness of measurement of serum (1®3)β-D-glucan in the diagnosis of pneumocystis jiroveci pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 559s Year: 2006
Serum KL-6 elevation related with severity in patients with pneumocystis pneumonia Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies Year: 2011
Serum KL-6 level is increased in patients with pneumocystis pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 101s Year: 2006
Evaluation of β-D-glucan, LD and KL-6 in the diagnosis and monitoring of Pneumocystis carinii pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 336s Year: 2003
Serum procalcitonin and community-acquired pneumonia in childhood Source: Eur Respir J 2005; 26: Suppl. 49, 167s Year: 2005
Usefulness of alveoloscopy in the diagnosis pf Pneumocystis jiroveci pneumonia in HIV+ patients Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009
Serum procalcitonin concentrations in children with pulmonary tuberculosis, tuberculous infection and lober pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 176s Year: 2003
Usefullness of CPR and PCT in the etiological diagnosis of community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011
Clinical prognostic factors for pneumocystis pneumonia in non-HIV patients Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012
Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
Serum albumin and probability of pleural effusion in patients with community-acquired pneumonia Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013
Pulmonary tuberculosis in the differential diagnosis of community-acquired pneumonia Source: Eur Respir J 2012; 40: 279 Year: 2012
Japanese guidelines for the management of community-acquired pneumonia: differential diagnosis of atypical pneumonia and bacterial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 374s Year: 2006
Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015
Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia Source: Eur Respir J 2008; 31: 356-362 Year: 2008
Value of hypoalbuminemia as a sign of severity of community-acquired pneumonia Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007
Outbreak of pneumocystis jiroveci pneumonia among renal transplant patients Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013
Prognosis of pneumocystis jirovecii pneumonia in non-HIV patients Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013